Your Gut Diversity Score Might Not Travel Outside Its Lab

If you've ever taken an at-home gut microbiome test and gotten back a single "diversity score," you've probably wondered how much that number actually means for your health. A new benchmark study, the largest of its kind, tested the most widely used gut-health scores against real disease outcomes in more than 12,000 people, then checked whether the winners held up in entirely different populations. The results are a useful reality check: the index that looks most convincing inside one dataset can fall apart the moment it's asked to generalize, which matters directly if you've ever leaned on a single diversity number to judge your own gut health.

Key takeaways:

• Researchers benchmarked 10 popular gut-microbiome health indices, including Shannon diversity, across more than 12,000 people and 10 outside validation cohorts.
• Shannon diversity, the most common score in consumer gut tests, best distinguished a healthy-lifestyle group within the original dataset, but failed to replicate in any external population.
• A structural-deviation score called the Microbiome Deviation Index (MDI) and a specific "risk bacteria" guild held up better across populations, though all three performed only modestly at actually predicting disease.
• No single index is reliable on its own; the authors recommend combining at least three different types of scores.

Study Benchmarks 10 Popular Gut-Microbiome Health Indices

Researchers tested 10 widely used summary scores, alpha-diversity metrics like Shannon diversity, taxonomic ratios like the Firmicutes/Bacteroidetes ratio, functional bacterial "guilds" such as butyrate producers, and a structural-deviation metric called the Microbiome Deviation Index (MDI), against real disease outcomes in the largest available citizen-science gut dataset. These build on a line of earlier proposals, including a predictive gut-health index introduced in 2020 that similarly tried to boil microbiome composition down to a single score. The index that performed best inside that single population, Shannon diversity (a common measure of how many different bacterial species are present and how evenly they're distributed), was also the one that failed hardest when the researchers tried it on ten independent populations elsewhere. Across cohorts, the ranking essentially inverted: the score that looked most convincing at home traveled the worst.

Why This Matters if You Track IBD, IBS, or a Metabolic Condition

Shannon diversity showed up as protective for 10 of 14 self-reported conditions within the main dataset, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), small intestinal bacterial overgrowth (SIBO), type 2 diabetes, and thyroid disorders. That's the kind of result that shows up in consumer gut-test reports and news coverage, and it's exactly the result this study shows doesn't hold up outside the original dataset. For readers managing one of these conditions and paying attention to direct-to-consumer gut microbiome test results, that's a meaningful caveat: a diversity score that looks reassuring, or alarming, may simply reflect the lab and population it was calibrated on rather than your actual disease risk.

Inside the 12,561-Person Benchmark and 10-Cohort Validation

The team drew its primary data from the American Gut Project, a large citizen-science cohort, analyzing 12,561 participants in total. Within that group, they defined a strict "Healthy Lifestyle" reference subset of just 177 people (based on normal BMI, a varied plant-based diet, regular exercise, no recent antibiotic use) and compared the 10 indices against the remaining 12,384 participants, then checked each index's associations with 14 self-reported chronic conditions. To test whether any index's performance would hold up elsewhere, the researchers then recomputed seven portable indices in 10 independent external cohorts (five type 2 diabetes cohorts and five inflammatory bowel disease cohorts) drawn from public metagenomic databases, and ran a formal cross-cohort prediction benchmark.

What This Means if You're Relying on a Gut Diversity Score

If you've paid for a commercial gut-microbiome test and received a diversity score, this study is a reason for caution rather than alarm: treat that single number as a rough, population-dependent signal, not a diagnosis or a reliable predictor of disease risk. Even the indices that performed best in cross-population testing here, the MDI and a "risk bacteria" bacterial guild, only reached modest predictive accuracy (areas under the curve in the 0.55 to 0.62 range, where 0.50 is chance and 1.0 is perfect), and demographic factors like age, sex, and BMI predicted disease about as well as any microbiome score. That doesn't mean gut composition is irrelevant to health, but it does mean no single score from any test, commercial or academic, should be treated as a stand-alone verdict on your gut health. If you're curious about a specific condition, this is worth raising with a doctor alongside other diagnostic tools, not instead of them.

Why a Cross-Sectional, Self-Reported Study Has Limits

This was a secondary analysis of existing, publicly available data, not a new clinical trial, and several limitations apply. Disease status came from participants' self-reports rather than clinical diagnoses, and the design is cross-sectional, meaning the study cannot establish whether a given microbiome score causes disease, reflects it, or neither. The 177-person "Healthy Lifestyle" reference group was small and skewed female, and the external validation cohorts were modestly sized (19 to 503 disease cases per cohort), which limits statistical power. The authors also note the MDI cannot be used as a fixed, portable score, it must be recalculated against each new population's own reference group, which complicates using it the way a consumer test typically presents a diversity number. This echoes a broader pattern seen elsewhere in the field: alpha-diversity metrics have also failed to reliably distinguish disease status in conditions like Parkinson's disease and multiple sclerosis, suggesting the generalization problem isn't unique to gut-disease associations. The study authors reported no conflicts of interest.

Next Steps: A Three-Index Framework Instead of One Score

Rather than recommend any single index, the research team proposes a "tri-axis" framework: pairing Shannon diversity (useful for describing a single population's internal state), the MDI (useful for flagging deviation from a population-specific healthy reference), and the risk bacteria guild (the most consistent performer across different populations) rather than relying on any one score for cross-population claims. The underlying code and data have been posted publicly, inviting other labs to test the same 10 indices against their own cohorts. The clearest open question the authors leave for future work is whether larger, more diverse external cohorts can push the risk-bacteria guild's cross-population signal for diabetes from "directionally consistent" to statistically confirmed.

Common Questions

Should I stop trusting my gut microbiome test's diversity score? Not necessarily, but treat it as one rough, population-dependent data point rather than a verdict on your health. This study found the most common diversity score didn't hold up across different populations.

What is the Microbiome Deviation Index (MDI)? It's a score measuring how far a person's gut bacterial makeup sits from a defined "healthy" reference group's average, rather than simply counting how many species are present. It performed more consistently than Shannon diversity across different populations in this study, though still with only modest predictive accuracy.

Does this mean gut bacteria don't matter for disease? No. It means a single summary score, especially one calibrated on only one population, is an unreliable way to capture that relationship. The study's authors still found meaningful, if modest, associations between specific indices and conditions like IBD and type 2 diabetes.

Why did Shannon diversity perform so differently in different populations? The researchers suggest that diversity and distance-based scores compress a whole bacterial community into a single number whose meaning shifts with diet, geography, and population structure, while a fixed set of disease-associated bacterial genera keeps a more consistent biological meaning across different groups of people.

References

1. Yu Sun, Yuwei Tang, Jieying Ou, et al. (2026). Benchmarking gut microbiome indices within and across populations. iMetaOmics. https://doi.org/10.1002/imo2.70148
2. Vinod K. Gupta, Minsuk Kim, Utpal Bakshi, et al. (2020). A predictive index for health status using species-level gut microbiome profiling. Nature Communications. https://doi.org/10.1038/s41467-020-18476-8
3. American Gut: an Open Platform for Citizen Science Microbiome Research (PMC). NIH. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954204/
4. Jonathan Plassais, Guillaume Gbikpi-Benissan, Marine Figarol, et al. (2021). Gut microbiome alpha-diversity is not a marker of Parkinson’s disease and multiple sclerosis. Brain Communications. https://doi.org/10.1093/braincomms/fcab113